37. Detection of hodgkin lymphoma within ovarian tissue
Sophie Bittinger(Royal Women's Hospital), Catharyn Stern(Royal Women's Hospital), Rosemary Harrup(University of Tasmania), Chandrika Parmar(Royal Women's Hospital), Debra A. Gook(Royal Women's Hospital), Simon Nazaretian(Royal Women's Hospital)
Cited by 2
Related Papers
Phase 1 study of the selective BTK inhibitor zanubrutinib in B-cell malignancies and safety and efficacy evaluation in CLL
|Blood|2019|369
Detection of Hodgkin lymphoma within ovarian tissue
|Fertility and Sterility|2010|71
Roxadustat for the treatment of anemia in patients with <scp>lower‐risk</scp> myelodysplastic syndrome: Open‐label, dose‐selection, lead‐in stage of a phase 3 study
|American Journal of Hematology|2021|58